Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02712853 · ClinicalTrials.gov registry record
Improving Autism Screening With Brain-Related miRNA
A clinical trial of Autism Spectrum Disorder and Developmental Delay, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- 304
- Enrollment target
- 1
- Study location
NCT02712853 is a study of Autism Spectrum Disorder and Developmental Delay that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 304 participants, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (127% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02712853, a study of Autism Spectrum Disorder and Developmental Delay, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- 304 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to identify specific miRNAs that are increased or decreased in the saliva of children with developmental delay and are useful for screening toddlers for ASD. Such a screening tool would improve the specificity of diagnosis, streamline referrals to developmental specialists, and expedite the arrangement of early intervention services.
Conditions Studied
Interventions
- OTHER Saliva collection
- OTHER Vineland Adaptive Behavior Scale-II Assessment
Study Locations (1)
Pennsylvania
- Penn State Milton S. Hershey Medical Center - Hershey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2015-11 |
| Est. Completion | 2018-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02712853
The ClinicalTrials.gov registry entry for NCT02712853 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 304 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 134-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (127% higher). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Saliva collection is the first listed.
NCT02712853 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02712853 about?
NCT02712853 is a clinical study titled "Improving Autism Screening With Brain-Related miRNA". The goal of this project is to identify specific miRNAs that are increased or decreased in the saliva of children with developmental delay and are useful for screening toddlers for ASD. Such a screening tool would improve the specificity of diagnosis, streamline referrals to developmental specialist...
What is the current status of trial NCT02712853?
This trial is currently completed. The enrollment target is 304 participants. The study started on 2015-11. Estimated completion is 2018-08.
What conditions does trial NCT02712853 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Developmental Delay.
What interventions are being tested in trial NCT02712853?
The interventions under investigation include: Saliva collection (OTHER), Vineland Adaptive Behavior Scale-II Assessment (OTHER).
Who is sponsoring clinical trial NCT02712853?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02712853 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.